MENU
NEWSLETTERS
MENU
SECTIONS
OTHER
CLASSIFIEDS
CONTACT US / FAQ
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY:EW)

84.15 +4.43 (+5.56%)
Official Closing Price Updated: 7:00 PM EDT, Apr 24, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
News headline image
Successful Patient Outcomes Demonstrated With Edwards’ SAPIEN M3 and EVOQUE Systems, New Data Presented at TCT 2025
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards SAPIEN 3 TAVR Delivers Proven Long-term Benefits and Valve Performance, New Data Presented at TCT 2025
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences to Host Earnings Conference Call on October 30, 2025
From Edwards Lifesciences Corporation
Via Business Wire
Nvidia, Citi, AT&T, Lucid, Edwards Sciences: What Sparked Heavy After-Hours Trading In These 5 Stocks? ↗
Via Stocktwits
News headline image
EW Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
From The Rosen Law Firm, P.A.
Via Business Wire
News headline image
EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Here's How Much $100 Invested In Edwards Lifesciences 15 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
Wealth Manager Doubles Down on Adobe, According to Recent SEC Filing ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Wealth Manager Takes Big New Stake in Visa, According to Latest Filing ↗
Via The Motley Fool
Topics Regulatory Compliance
News headline image
EW Investor News: Rosen Law Firm Investigates Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
Which S&P500 stocks are gapping on Wednesday? ↗
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Wednesday to uncover the stocks that are gapping in the S&P500 index. 
Via Chartmill
News headline image
Here's How Much You Would Have Made Owning Edwards Lifesciences Stock In The Last 20 Years ↗
Edwards Lifesciences (NYSE: EW) has outperformed the market over the past 20 years by 7.57% on an annualized basis producing an average annual return of 16.53%. Currently, Edwards Lifesciences has a... 
Via Benzinga
News headline image
EW Investor News: If You Have Suffered Losses in Edwards Lifesciences Corporation (NYSE: EW), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
From The Rosen Law Firm PA
Via GlobeNewswire
News headline image
EW Investor News: Rosen Law Firm Announces Investigation of Breaches of Fiduciary Duties by the Directors and Officers of Edwards Lifesciences Corporation – EW
From Rosen Law Firm
Via Business Wire
News headline image
Analyst Expectations For Edwards Lifesciences's Future ↗
 
Via Benzinga
News headline image
EDWARDS (EW) ALERT: Bragar Eagel & Squire, P.C. is Investigating Edwards Lifesciences Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings ↗
One was recently acquired by a much bigger company. 
Via The Motley Fool
Topics Artificial Intelligence Energy
News headline image
3 Healthcare Pathbreakers With Long-Term Tailwinds ↗
These three firms in the fast-changing healthcare sector stand out to analysts for their strong product lineups, defensible technology, and notable pipelines. 
Via MarketBeat
News headline image
Updated ESC/EACTS Guidelines Mark Advancement in Structural Heart Disease Care
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Israel Englander's Millennium Goes All-In On Crypto And Healthcare While Rebalancing Big Tech Bets: Bitcoin ETF And Palantir Stakes Soar In Q2 ↗
Millennium Management's Q2 2025 13F reveals big bets on crypto (IBIT, PLTR) & healthcare (EW, INSM), with tech rebalancing. Read key changes! 
Via Benzinga
Topics ETFs
News headline image
Here's How Much $100 Invested In Edwards Lifesciences 20 Years Ago Would Be Worth Today ↗
 
Via Benzinga
News headline image
If You Invested $1000 In This Stock 15 Years Ago, You Would Have This Much Today ↗
 
Via Benzinga
News headline image
Edwards Lifesciences Announces $500 Million Accelerated Share Repurchase
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
EDWARDS (EW) ALERT: Bragar Eagel & Squire, P.C. is Investigating Edwards Lifesciences Corporation on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
From Bragar Eagel & Squire
Via GlobeNewswire
News headline image
Here Are Billionaire Ken Griffin's 5 Biggest Stock Holdings ↗
A longtime leader in financial services tops the list. 
Via The Motley Fool
News headline image
Deal Dispatch: Performance Food Group And Claire's Lead A Week Of Big Auctions, Retail Woes ↗
Performance Food rejects offer; Lufthansa drops Air Europa bid; NFL inks deal with ESPN; Claire's files bankruptcy amid retail struggles. 
Via Benzinga
Topics Bankruptcy
News headline image
FTC Sounds Alarm On Edwards' Attempt To Corner Heart Device Market ↗
The FTC complaint alleges that if Edwards acquires JenaValve, it would gain control over the two most advanced TAVR-AR devices. 
Via Benzinga
News headline image
Edwards Lifesciences Comments on FTC’s Action to Block Proposed Acquisition of JenaValve
From Edwards Lifesciences Corporation
Via Business Wire
News headline image
Edwards Lifesciences Stock: Likely To See Sluggish Price Action Through 2027 ↗
Edwards Lifesciences may avoid bearishness but is likely to trade sluggishly through 2027, as key cycle phases signal limited upside potential. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
22 23 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story